F353-0767 Screening compound: 6-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-1-benzyl-3-methyl-1,2-dihydroquinoxalin-2-one

F353-0767 Screening compound: 6-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-1-benzyl-3-methyl-1,2-dihydroquinoxalin-2-one
F353-0767 Screening compound: 6-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-1-benzyl-3-methyl-1,2-dihydroquinoxalin-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F353-0767
6-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-1-benzyl-3-methyl-1,2-dihydroquinoxalin-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F353-0767

Molecular Formula

C29H28N4O4 (C29 H28 N4 O4)

Compound Name

6-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-1-benzyl-3-methyl-1,2-dihydroquinoxalin-2-one

IUPAC name

6-{4-[(2H-13-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-1-benzyl-3-methyl-12-dihydroquinoxalin-2-one

SMILES

CC1=Nc(cc(cc2)C(N3CCN(Cc(cc4)cc5c4OCO5)CC3)=O)c2N(Cc2ccccc2)C1=O

InChI

InChI=1S/C29H28N4O4/c1-20-28(34)33(18-21-5-3-2-4-6-21)25-9-8-23(16-24(25)30-20)29(35)32-13-11-31(12-14-32)17-22-7-10-26-27(15-22)37-19-36-26/h2-10,15-16H,11-14,17-19H2,1H3

InChI Key

NISITMWJDGVDAV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27118375

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

496.57

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.117

Distribution Coefficient, logD

2.925

Water Solubility, LogSw

-3.26

Polar Surface Area

59.927

Acid Dissociation Constant (pKa)

26.18

Base Dissociation Constant (pKb)

7.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.60

F353-0767 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with F353-0767 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F353-0767?
Check Price and Availability of F353-0767, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F353-0767 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F353-0767
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F353-0767
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F353-0767 available by request